Disease Info Card

Primary Congenital Glaucoma

Information about Primary Congenital Glaucoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Primary Congenital Glaucoma

Most recent studies have shown that Primary Congenital Glaucoma shares some biological mechanisms with aniridia, aqueous-humor-disorders, blind-vision, cataract, congenital-abnormality, corneal-diseases, corneal-edema, disorder-of-eye, edema, eye-abnormalities, glaucoma, glaucoma-open-angle, hemorrhage, hydrophthalmos, hyphema, intraocular-pressure-disorder, primary-open-angle-glaucoma, retinal-detachment, rieger-syndrome, secondary-glaucoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Primary Congenital Glaucoma, and have been seen in publications frequently: Cell Adhesion, Developmental Process, Electron Transport, Electron Transport Chain, Enucleation, Eye Development, Eye Morphogenesis, Localization, Mitochondrial Fission, Neuroblast Division, Pathogenesis, Pigmentation, Secretion, Tissue Development, Translation, Transport

Quite a number of genes have been found to play important roles in Primary Congenital Glaucoma, such as BRCA1, CYP1A2, CYP1B1, DCT, FOXC1, GLYAT, LTBP2, LTBP3, MYOC, OPTN, PAX6, PITX2, RANGAP1, SLC17A5, TYR, TYRP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.